Bristol Myers Squibb (BMY) Income from Non-Controlling Interests (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Income from Non-Controlling Interests for 18 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Income from Non-Controlling Interests fell 150.0% year-over-year to -$1.0 million in Q2 2026; TTM through Jun 2026 was -$7.0 million, a 143.75% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 86.67% from the prior year.
• Income from Non-Controlling Interests was -$1.0 million for Q2 2026 at Bristol Myers Squibb, down from $1.0 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $8.0 million in Q2 2022 and troughed at -$6.0 million in Q3 2025.
• A 5-year average of $2.9 million and a median of $4.0 million in 2023 frame the typical range for Income from Non-Controlling Interests.
• Across the five-year window, Income from Non-Controlling Interests soared 200.0% in 2023 and slumped 250.0% in 2025, its largest moves.
• Over 5 years, Income from Non-Controlling Interests stood at $3.0 million in 2022, then soared by 100.0% to $6.0 million in 2023, then plunged by 33.33% to $4.0 million in 2024, then tumbled by 125.0% to -$1.0 million in 2025, then changed by 0.0% to -$1.0 million in 2026.
• The last three Income from Non-Controlling Interests figures came in at -$1.0 million (Q2 2026), $1.0 million (Q1 2026), and -$1.0 million (Q4 2025), per Business Quant data.